Swollen lymph node metastasis and survival in gastric cancer: Multi-institutional post-resection analysis

doi:10.5306/wjco.v16.i6.106228

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (24)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

HTML

Figures (1-3)

Tables (1-4)

Sum=23

Jun 24, 2025 (publication date) through Jun 20, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Oncol. Jun 24, 2025; 16(6): 106228
Published online Jun 24, 2025. doi: 10.5306/wjco.v16.i6.106228

Full Size Figure Download Figure

Figure 1 Kaplan–Meier estimates of overall survival in patients with gastric cancer after curative resection according to the status of swollen lymph node metastasis. A: Overall survival (OS) curve for all patients: The 5-year OS rates were 136% and 35.8% for patients with swollen lymph node metastasis (SLNM) and those without, respectively (P < 0.001); B: OS curve for matched patients: The 5-year OS rates were 134% and 21.2% for patients with SLNM and those without, respectively (P = 0.006).

Citation: Cui JL, Zhao K, Li XL, Wang F, Yang YS, Zheng X. Swollen lymph node metastasis and survival in gastric cancer: Multi-institutional post-resection analysis. World J Clin Oncol 2025; 16(6): 106228
URL: https://www.wjgnet.com/2218-4333/full/v16/i6/106228.htm
DOI: https://dx.doi.org/10.5306/wjco.v16.i6.106228